MXPA02012000A - Nuevos compuestos de la familia de las n-acilaminoamidas composiciones que los contienen y usos. - Google Patents

Nuevos compuestos de la familia de las n-acilaminoamidas composiciones que los contienen y usos.

Info

Publication number
MXPA02012000A
MXPA02012000A MXPA02012000A MXPA02012000A MXPA02012000A MX PA02012000 A MXPA02012000 A MX PA02012000A MX PA02012000 A MXPA02012000 A MX PA02012000A MX PA02012000 A MXPA02012000 A MX PA02012000A MX PA02012000 A MXPA02012000 A MX PA02012000A
Authority
MX
Mexico
Prior art keywords
acylamino
compositions
novel compounds
same
amide family
Prior art date
Application number
MXPA02012000A
Other languages
English (en)
Inventor
Maria Dalko
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Publication of MXPA02012000A publication Critical patent/MXPA02012000A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06052—Val-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Abstract

La presente invencion se relaciona con nuevos compuestos de la familia de las N-acilaminoamidas, con su utilizacion especialmente en cosmetica o en farmacia y con las composiciones que los contienen y su utilizacion, para tratar los signos del envejecimiento de la piel del cuerpo o de la cara, ya sea cronobiologico o fotoinducido y, especialmente, el envejecimiento generado por una disminucion de la elasticidad de la piel y/o por una degradacion del colageno en la estructura de los tejidos.
MXPA02012000A 2000-06-08 2001-05-21 Nuevos compuestos de la familia de las n-acilaminoamidas composiciones que los contienen y usos. MXPA02012000A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0007344A FR2810033B1 (fr) 2000-06-08 2000-06-08 Nouveaux composes de la famille des n-acylamino-amides, compositions les comprenant, et utilisations
PCT/FR2001/001559 WO2001094381A2 (fr) 2000-06-08 2001-05-21 Nouveaux composes de la famille des n-acylamino-amides, compositions les comprenant, et utilisations

Publications (1)

Publication Number Publication Date
MXPA02012000A true MXPA02012000A (es) 2003-04-22

Family

ID=8851090

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02012000A MXPA02012000A (es) 2000-06-08 2001-05-21 Nuevos compuestos de la familia de las n-acilaminoamidas composiciones que los contienen y usos.

Country Status (18)

Country Link
US (4) US6987128B2 (es)
EP (1) EP1292608B1 (es)
JP (1) JP3843943B2 (es)
KR (1) KR20030022138A (es)
CN (1) CN1436197A (es)
AR (1) AR028678A1 (es)
AT (1) ATE271562T1 (es)
AU (1) AU2001262475A1 (es)
BR (1) BR0111648A (es)
CA (1) CA2408670A1 (es)
DE (1) DE60104423T2 (es)
ES (1) ES2223862T3 (es)
FR (1) FR2810033B1 (es)
HU (1) HUP0302744A2 (es)
MX (1) MXPA02012000A (es)
PL (1) PL359064A1 (es)
RU (1) RU2002135598A (es)
WO (1) WO2001094381A2 (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4448006A (en) 1981-05-28 1984-05-15 Donn Incorporated Grid ceiling structure and method of converting
FR2810033B1 (fr) * 2000-06-08 2004-04-30 Oreal Nouveaux composes de la famille des n-acylamino-amides, compositions les comprenant, et utilisations
FR2826267B1 (fr) * 2001-06-26 2005-02-25 Oreal Composition cosmetique ou dermatologique comprenant une association entre un compose inhibiteur de l'elastase de la famille des n-acylaminoamides et au moins un agent myorelaxant
FR2826266B1 (fr) 2001-06-26 2005-02-25 Oreal Composition cosmetique ou dermatologique comprenant une association entre un compose de la famille des n-acylaminoamides et au moins un inhibiteur de metalloproteinases matricielles
FR2826263B1 (fr) * 2001-06-26 2005-02-25 Oreal Composition cosmetique ou dermatologique comprenant une association entre un compose inhibiteur de l'elastase de la famille des n-acylaminoamides et au moins un compose anti-inflammatoire
FR2826265B1 (fr) * 2001-06-26 2005-02-18 Oreal Composition cosmetique ou dermatologique comprenant une association entre un inhibiteur de l'elastase de la famille des n-acylaminoamides et au moins un agent antifongique et/ou antibacterien
FR2826262B1 (fr) * 2001-06-26 2005-02-25 Oreal Composition cosmetique ou dermatologique comprenant une association entre un compose de la famille des n-acylaminoamides et au moins un compose agissant sur la chute ou la repousse des cheveux
FR2847816B1 (fr) * 2002-12-03 2005-01-14 Oreal Composition comprenant un pseudodipeptide et un agent augmentant la synthese d'elastine
FR2878156A1 (fr) * 2004-11-22 2006-05-26 Oreal Utilisation des composes de la famille des n-acylamino-amides comme agents apaisants
WO2006053789A1 (en) * 2004-11-22 2006-05-26 L'oreal Protection of the skin against deterioration linked to a stress-induced dysfunction of the apoptotic and immune defence processes
FR2878155A1 (fr) * 2004-11-22 2006-05-26 Oreal Protection de la peau contre les alterations liees a un dysfonctionnement des mecanismes physiologiques d'apoptose
WO2006053790A1 (en) * 2004-11-22 2006-05-26 L'oreal Use of compounds of the n-acylaminoamide family as soothing or calming agents
FR2895256B1 (fr) * 2005-12-22 2008-10-10 Oreal Composition associant un extrait de bacterie filamenteuse non photosynthetique non fructifiante de la famille des n-acylamino-amides.
FR2895254B1 (fr) * 2005-12-22 2008-02-15 Oreal Kit de soin de traitement associant un extrait de bacterie filamenteuse non photosynthetique non fructifiante et un actif cosmetique.
US7666946B2 (en) * 2006-01-27 2010-02-23 Arkema Inc. Blends of biopolymers with acrylic copolymers
FR2897776B1 (fr) * 2006-02-28 2008-04-18 Oreal Composition cosmetique anti-age
FR2902998B1 (fr) * 2006-07-03 2012-09-21 Oreal Utilisation d'au moins un derive c-glycoside a titre d'agent apaisant
FR2903002B1 (fr) * 2006-07-03 2012-08-17 Oreal Composition associant un derive c-glycoside et un polymere emulsionnant
FR2902996B1 (fr) * 2006-07-03 2008-09-26 Oreal Compositions cosmetiques associant un derive c-glycoside et un derive n-acylaminoamide
FR2902999B1 (fr) * 2006-07-03 2012-09-28 Oreal Utilisation de derives c-glycoside a titre d'actif prodesquamant
FR2903003B1 (fr) * 2006-07-03 2012-08-17 Oreal Utilisation d'un derive c-glycoside pour ameliorer la fonction barriere de la peau
FR2903004B1 (fr) * 2006-07-03 2009-07-10 Oreal Utilisation en cosmetique d'un derive c-glycoside en association avec de l'acide ascorbique
FR2918269B1 (fr) 2007-07-06 2016-11-25 Oreal Composition de protection solaire contenant l'association d'un polymere semi-cristallin et de particules de latex creuses.
FR2918561B1 (fr) 2007-07-09 2009-10-09 Oreal Utilisation pour la coloration de la peau de l'acide dehydroascorbique ou des derives polymeres ; procedes de soin et/ou de maquillage.
FR2918563B1 (fr) 2007-07-12 2009-12-04 Oreal Composition photoprotectrice fluide aqueuse a base d'un polymere polyamide a terminaison amide tertiaire.
FR2931064B1 (fr) 2008-05-14 2010-08-13 Oreal Composition cosmetique contenant un derive de dibenzoylmethane et un derive de pyrrolidinone; procede de photostabilisation du derive de dibenzoylmethane
US8927617B2 (en) * 2008-06-30 2015-01-06 Kimberly-Clark Worldwide, Inc. Fragranced water-sensitive film
FR2936706B1 (fr) 2008-10-08 2010-12-17 Oreal Composition cosmetique contenant un derive de dibenzoylmethane et un compose dithiolane ; procede de photostabilisation du derive de dibenzoylmethane
FR2939036B1 (fr) 2008-12-01 2010-12-17 Oreal Procede de coloration artificielle de la peau utilisant un melange de carotenoide et de colorant vert lidophile ; nouveau melange de colorants lipophiles ; composition
FR2940609B1 (fr) 2008-12-30 2011-05-06 Oreal Association de monosaccharides et d'agents desquamants et son utilisation en cosmetique
FR2940613B1 (fr) 2008-12-30 2012-09-21 Oreal Association de monosaccharides avec des filtres solaires et son utilisation en cosmetique
FR2940612B1 (fr) 2008-12-30 2011-05-06 Oreal Association de monosaccharides avec l'acide ascorbique et son utilisation en cosmetique
FR2940608B1 (fr) 2008-12-30 2011-04-22 Oreal Utilisation de monosaccharides et composition
FR2940611B1 (fr) 2008-12-30 2012-01-13 Oreal Association de monosaccharides et d'adenosine et son utilisation en cosmetique
FR2940610B1 (fr) 2008-12-30 2011-05-06 Oreal Association de monosaccharides avec des derives c-glycosides et son utilisation en cosmetique
FR2940615B1 (fr) 2008-12-30 2011-12-30 Oreal Association de monosaccharides avec des agents antioxydants et son utilisation en cosmetique
CA2769512C (en) 2009-07-29 2019-07-09 Duke University Compositions comprising fp receptor antagonists and their use for inhibiting hair growth
EP2512417A2 (fr) 2009-12-18 2012-10-24 L'Oréal Procede de traitement cosmetique impliquant un compose apte a condenser in situ et un agent filtrant les radiations uv
FR2960773B1 (fr) 2010-06-03 2015-12-11 Oreal Procedes de traitement cosmetique utilisant un revetement a base d'un polymere polyamide-polyether
FR2979540B1 (fr) 2011-09-06 2013-12-27 Oreal Association de carraghenane et de c-glycoside et leurs utilisations
FR3030523B1 (fr) 2014-12-18 2017-01-20 Oreal Nouveaux composes de la famille des n-acylamino-amides,compositions les comprenant, et utilisations
EP3434255A1 (en) * 2017-07-26 2019-01-30 L'oreal Iontophoresis method, composition and kit for delivering n-acetyl-3-trifluoromethyl-phenyl-(valine-glycine) through the skin
US10449133B1 (en) 2018-08-23 2019-10-22 L'oreal Cosmetic compositions comprising acetyl trifluoromethylphenyl valylglycine
JP7378927B2 (ja) * 2018-12-17 2023-11-14 ロレアル マイクロニードルシート
CN110128500B (zh) * 2019-04-29 2020-12-22 杭州迈世腾药物科技有限公司 制备α-酰胺基酰胺类物质的Ugi混合溶剂法
FR3097434B1 (fr) 2019-06-19 2022-03-25 Oreal Compositions comprenant au moins un composé de la famille des N-acylamino-amides et au moins un alkylpolyglycoside
FR3124952A1 (fr) * 2021-07-09 2023-01-13 L'oreal Procédés et compositions pour l’amélioration de la peau

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1415229A (fr) * 1963-11-26 1965-10-22 Bayer Ag Procédé de préparation d'amides et peptides de nu-acyl-alpha-aminoacides
FR2672288B1 (fr) 1991-02-06 1993-04-23 Oreal Nouveaux amides dipeptidiques derivant de la glycyl-serine, utilisables, notamment dans des compositions cosmetiques, pharmaceutiques ou alimentaires.
IL111730A (en) * 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives, processes for their preparation and pharmaceutical preparations containing them
AUPP616598A0 (en) * 1998-09-25 1998-10-15 University Of Queensland, The Auxiliary for amide bond formation
AUPP616498A0 (en) * 1998-09-25 1998-10-15 University Of Queensland, The Synthesis of cyclic peptides
FR2810033B1 (fr) * 2000-06-08 2004-04-30 Oreal Nouveaux composes de la famille des n-acylamino-amides, compositions les comprenant, et utilisations

Also Published As

Publication number Publication date
EP1292608B1 (fr) 2004-07-21
US20110021438A1 (en) 2011-01-27
ES2223862T3 (es) 2005-03-01
US7786321B2 (en) 2010-08-31
US20030152600A1 (en) 2003-08-14
RU2002135598A (ru) 2004-05-10
US7419970B2 (en) 2008-09-02
US20050187197A1 (en) 2005-08-25
CA2408670A1 (fr) 2001-12-13
EP1292608A2 (fr) 2003-03-19
WO2001094381A2 (fr) 2001-12-13
DE60104423D1 (de) 2004-08-26
HUP0302744A2 (hu) 2003-11-28
US20060211659A9 (en) 2006-09-21
KR20030022138A (ko) 2003-03-15
AR028678A1 (es) 2003-05-21
US6987128B2 (en) 2006-01-17
JP3843943B2 (ja) 2006-11-08
AU2001262475A1 (en) 2001-12-17
FR2810033A1 (fr) 2001-12-14
JP2003535872A (ja) 2003-12-02
US7998933B2 (en) 2011-08-16
CN1436197A (zh) 2003-08-13
ATE271562T1 (de) 2004-08-15
FR2810033B1 (fr) 2004-04-30
DE60104423T2 (de) 2005-08-25
WO2001094381A3 (fr) 2002-06-27
BR0111648A (pt) 2003-07-01
PL359064A1 (en) 2004-08-23
US20080293962A1 (en) 2008-11-27

Similar Documents

Publication Publication Date Title
MXPA02012000A (es) Nuevos compuestos de la familia de las n-acilaminoamidas composiciones que los contienen y usos.
EP1159952A4 (en) COSMETIC PREPARATIONS
HK1063291A1 (en) Use of phaeodactylum algae extract to promote the proteasome activity of skin cells
MXPA02007059A (es) Composicion de autobronceado que contiene un ester n-acilado de aminoacido y un agente de autobronceado.
PL1738747T3 (pl) Zastosowanie zasady salicyloilo-sfingoidowej do leczenia lub zapobiegania celulitowi
ATE273690T1 (de) Zusammensetzung zur hautdesinfizierung
PL323364A1 (en) Bicyclic aromatic compounds
NZ505742A (en) Compositions containing aminobiguanides with antimicrobial activity used to treat contact lenses
MX9805705A (es) Compuestos biaromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
HK1112721A1 (en) Tissue disruption treatment and composition for use thereof
NZ328874A (en) Heterocyclic biaryl compounds and their use in pharmaceutical compositions for treatment of dermatological, rheumatic, respiratory, cardiovascular and ophthalmological disorders
MXPA02002117A (es) Uso de productos leguminosos para el tratamiento de agresiones externas.
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
ATE422892T1 (de) Verwendung von hyaluronsäure zur herstellung von zusammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle
MXPA04001328A (es) Productos en combinacion de derivados de 1,4-benzotiepina-1,1-dioxido con otros ingredientes activos, y su uso.
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
HK1111924A1 (en) Depigmenting or brightening cosmetic composition comprising at least one oxazolin as an active ingredient
WO2002034210A3 (fr) Utilisation de l'association d'au moins un carotenoide et de vitamine c pour traiter les signes cutanes du vieillissement
DE60036725D1 (de) Zusammensetzungen enthaltend vernix und ein uv-schutzmittel, und deren verwendung
BR0113886A (pt) Composição, composição farmacêutica, tratamento de combinação para prevenir ou inibir a geração ou atividade de trombina num paciente, método para inibir ou prevenir a geração ou atividade de trombina num paciente, uso de uma composição ou tratamento de combinação, uso de uma composição, uso e kit
AU2003214288A8 (en) Cosmetic composition for treatment against skin ageing
AU2002360115A1 (en) Use of ganoderic acids as cosmetic agents and for treating or preventing skin disorder and corresponding composition
AU2003238406A1 (en) Compositions containing dolichol for dermatological and cosmetic use
GB0209376D0 (en) Compositions for the treatment of wounds and damaged dermal tissue
ITMI20032254A1 (it) Uso di perfluoropolieteri fosfati come agenti stabilizzanti per polifenoli e composizioni cosmetiche e/o dermatologiche contenenti polifenoli stabilizzate da perfluoropolieteri fosfati.